ARIA
ARIA is swelling or bleeding seen on MRI in people receiving amyloid antibodies. It can be silent or, less often, symptomatic.
Overview
ARIA-E is oedema. ARIA-H is haemorrhage. Risk is higher in ApoE ε4 carriers. Monitoring schedules live on the product label, not on this glossary card.
Similar pages
not linked directly; found by shared links- TechnologyApoE testing
Shares Donanemab, Lecanemab, Alzheimer’s disease and the tag dementia-atlas.
- TechnologyAnti-amyloid antibodies
Shares Donanemab, Lecanemab, Alzheimer’s disease and the tag dementia-atlas.
- IdeaAntibody trials that enrol mixed and comorbid disease
Shares Donanemab, Lecanemab, Alzheimer’s disease and the tag dementia-atlas.
- TechnologyBrain MRI
Shares Lecanemab with MRI monitoring, Alzheimer’s disease and the tag dementia-atlas.
- TargetAmyloid-beta
Shares Donanemab, Lecanemab, Alzheimer’s disease and the tag dementia-atlas.
- TrialTRAILBLAZER-ALZ 2
Shares Donanemab, Alzheimer’s disease and the tag dementia-atlas.
- CompanyEisai
Shares Lecanemab, Alzheimer’s disease and the tag dementia-atlas.
- DiagnosisMild cognitive impairment
Shares Donanemab, Lecanemab, Alzheimer’s disease and the tag dementia-atlas.